Insuficiencia cardiaca avanzada e transplante cardiaco: Envíos recentes
Mostrando ítems 41-45 de 184
-
Pulmonary vascular remodeling and prognosis in patients evaluated for heart transplantation: insights from the OCTOPUS-CHF study
(MDPI, 2022-12-06)[Abstract] Objective: In patients with advanced heart failure, the intravascular optical coherence tomography (OCT) of subsegmental pulmonary artery measurements is correlated with right heart catheterization parameters. ... -
Omecamtiv mecarbil for patients with severe systolic dysfunction and hypotension
(Oxford Academic, 2022-12-21) -
Código shock cardiogénico 2023: documento de expertos para una organización multidisciplinaria que permita una atención de calidad
(Elsevier, 2022-11-18)[Resumen] Pese a los esfuerzos realizados para mejorar la atención al shock cardiogénico (SC), incluyendo el desarrollo de dispositivos de asistencia circulatoria mecánica (ACM), su pronóstico continúa siendo desfavorable. ... -
Beta-blocker exposure and survival in patients with transthyretin amyloid cardiomyopathy
(Elsevier, 2022-02)[Abstract] Objective: To investigate a potential association between beta-blocker exposure and survival in patients with transthyretin amyloid cardiomyopathy (ATTR-CM). Methods: In this real-world prospective registry ... -
Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world
(Wiley, 2019-05-27)[Abstract] Aims: To assess the proportion of patients with heart failure and reduced ejection fraction (HFrEF) who are eligible for sacubitril/valsartan (LCZ696) based on the European Medicines Agency/Food and Drug ...